EGFR and head and neck squamous cell carcinoma: Since human epidermal growth factor receptor (EGFR) has a pivotal role in carcinogenesis and HNSCCs show significantly increased EGFR expression, several EGFR inhibitors were developed and tested for HNSCC treatment in the past few decades [4].